Grigoriy Yakubovskiy

Dr. Grigoriy Yakubovskiy

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2022 in The Clinician
Verified
Journal Article
Open access
PDF file
NAN. S. Asfandiyarova
N. S. Asfandiyarova
EPE. V. Philippov
E. V. Philippov
ODO. V. Dashkevich
O. V. Dashkevich
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
KMK. A. Moseichuk
K. A. Moseichuk
EFE. N. Fedyaeva
E. N. Fedyaeva
Aim: to study risk factors of development of the post-COVID syndrome (PCS).Material and methods. 210 patients with a history of new coronavirus infection (COVID-19) (47 men, 163 women aged 18–85 years) were examined by doctors of various specialties. Patients were divided into several groups depending on the presence of PCS, as well as the severity of the disease.Results. The risk factors of the PCS development are moderate and severe course of the pathological process in acute period of COVID-19 disease (p 0.001). In women, PCS is seen more often than in men (30 / 135 vs. 17 / 28, p 0 / 001), other risk factors are age over 50 years (p 0.05), polymorbidity (p 0.01), treatment with glucocorticoids in acute disease period (76 / 165 vs. 4 / 45, p 0.001). In cases of mild COVID-19 course, neither age nor polymorbidity increased the risk of PCS development (p 0.05), however a dysfunction of cellular immunity was significant, specifically the proliferative activity of lymphocytes in response to mitogen: 50.6 ± 10.4 % vs. 54.0 ± 5.1 %, p 0.05). In cases of severe COVID-19 course, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development (p 0.05), however the age (56.7 ± 13.1 years vs. 42.1 ± 15.4 years, p 0.01) its linkage to somatic pathology (a cardiovascular disease) besides glucocorticoids threatment (64 / 89 vs. 3 / 9, p 0.05) are important risk factors for PCS.Conclusions. The main risk factor for PCS development is the moderate and severe course of the pathological process in the acute period of COVID-19 infection, female gender, age over 50 years, polymorbidity, treatment with glucocorticoids in the disease acute period. In case of mild COVID-19 course, neither age nor the polymorbidity increased the risk of PCS development, but the dysfunction of cellular immunity is significant. In case of severe COVID-19, the gender differences and dysfunction of the cellular immune system are not the determinants for the PCS development, however age, concomitant somatic pathology (a cardiovascular disease) and glucocorticoids treatment in acute period are important risk factors for the PCS development. The titer of protective IgG class antibodies to SARS-CoV-2 is not linked to risk of the PCS development.

31 March 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
NANailya S. Asfandiyarova
Nailya S. Asfandiyarova
RURyazan State Medical University
Ryazan State Medical University
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
INTRODUCTION: Benign hyperbilirubinemia of Gilbert type affects 10% of population, most commonly men of 20–30 years of age. In the article, description of a classic clinical case illustrating the course of Gilbert syndrome, is given. After an intercurrent infection, a 32-year old man presented with jaundice with elevation of the level of unconjugated bilirubin against the normal background level of enzymes. Bearing in mind a probability of being excluded from the flight crew, the patient agreed to the puncture biopsy of the liver, and the morphological examination of the hepatic tissue confirmed the diagnosis of benign hyperbilirubinemia of Gilbert type. A molecular genetic examination also showed the existence of tyrosine-arginine repeats in the promotor region of uridine diphosphate–glucuronosyltransferase gene. Adequately selected treatment with phenobarbital stimulating the activity of the enzyme, led to normalization of bilirubin level and to improvement of the patient’s well-being. CONCLUSION: Chronic familial non-hemolytic hyperbilirubinemias are often given insufficient attention not only due to the fact that their outcomes do not pose a serious threat to the patient’s health, and, according to the erroneous opinion, are rare, but to a larger extent due to the fact that the diagnosis presents certain difficulties for a therapist or a general practitioner.

7 April 2024 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
DBDmitriy Yu. Boyakov
Dmitriy Yu. Boyakov
VPVadim S. Petrov
Vadim S. Petrov
ANAleksandr A. Nikiforov
Aleksandr A. Nikiforov
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
OKOl'GA V. Kodyakova
Ol'GA V. Kodyakova
БЮБояков Дмитрий Юрьевич
Бояков Дмитрий Юрьевич
INTRODUCTION: The role of genetic factors in the development of cardiovascular diseases (CVD) in patients with inflammatory bowel diseases (IBD) is practically unknown. AIM: To study the frequency of carriage of allelic polymorphous variants of NOD2/CARD15 (3020insC rs5743293, Gly908Arg rs2066845), CRP (+1444CT rs1130864), FTO (A23525T rs9939609) genes and to perform a comprehensive assessment of damage to the target organs, diastolic myocardial dysfunction of the left ventricle and CVD in patients with ulcerative colitis and Crohn’s disease living in the Ryazan District. MATERIALS AND METHODS: The study involved 62 patients (41 (66%) women, 40.5 [33.5; 52.25] years old) with IBD (51 patients with ulcerative colitis, 11 patients with Crohn’s disease) in whom 3020insC and Gly908Arg polymorphisms in CARD15 (NOD2) gene, C1444T in CRP gene and А23525Т in FTO gene were determined using allele-specific polymerase chain reaction. After that, the frequency of carriage of their allelic variants and association with CVRFs, damage to the target organs (through evaluation of the arterial stiffness, pulse pressure, hypertrophy of the left ventricular myocardium, ankle-brachial index) and CVDs was evaluated. RESULTS: According to the aims of the study, the frequency of carriage of allelic polymorphic variants of genes was determined: 3020insC in gene CARD15 (NOD2) rs5743293 85.5% — homozygote for allele 1, 14,5% — heterozygote; Gly908Arg in gene CARD15 (NOD2) rs2066845 93.5% — homozygote for allele 1, 6.5% — heterozygote; C1444T in gene CRP rs1130864 50% — homozygote for allele 1, 41.9% — heterozygote, 8.1% — homozygote for allele 2; А23525Т in gene FTO rs9939609 38.7% — homozygote for allele 1, 38.7% — heterozygote, 22.6% — homozygote for allele 2. The prevalence of arterial hypertension was 31%, of obesity by body mass index — 18%, by waist circumference — 29%, and of dyslipidemia — 53%. Statistically significant associations were found between: 1) hypercholesterolemia and Gly908Arg polymorphism in gene CARD15 (NOD2) rs2066845 (÷2 = 6.005; p = 0.014), 2) family history of early CVD and 3020insC polymorphism in gene CARD15 (NOD2) rs2066845 (÷2 = 4.561; p = 0.033), 3) arterial hypertension and 3020insC polymorphism in genеCARD15 (NOD2) rs5743293 (÷2 = 4.65; p = 0.031). CONCLUSION: The prevalence of arterial hypertension, obesity and dyslipidemia in patients with IBD is considerably lower in the given study than in the individuals of comparable age in the epidemiological MERIDIAN-RO study conducted in the Ryazan region. Statistically significant associations were found between the studied polymorphisms and hypercholesterolemia, family history of early cardiovascular diseases and arterial hypertension.

15 March 2014 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
ANA A Nizov
A A Nizov
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
EKE I Koldynskaya
E I Koldynskaya
The efficacy analysis of patient management in inflammatory bowel diseases is provided in the article. The most frequent mistakes in medicament prescription are reviewed. The data are shown on prevalence and management of anemia in this group of patients. The information is given on quality of life in patients with inflammatory bowel diseases and it's connection with the characteristics of the diseases course.

18 January 2023 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
EKE. I. Koldynskaia
E. I. Koldynskaia
Thyrotoxic hepatitis develops in 55-60% of patients with hyperthyroidism, it is often asymptomatic and diagnosed incidentally. The article describes a clinical case of thyrotoxic hepatitis in a 50-year-old female. The case seems to be rare as the overt signs of hyperthyroidism manifested in the patient 5 months later than the changes in liver function tests in blood. The current data on the epidemiology, pathogenesis and clinical picture of liver damage in thyrotoxicosis are represented in discussion.

28 March 2026 in Yakut Medical Journal
Verified
Journal Article
Open access
PDF file
NEN. V. Enenkov
N. V. Enenkov
AEA. O. Enenkova
A. O. Enenkova
GYGrigoriy Yakubovskiy
Grigoriy Yakubovskiy
Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) is a rare disorder with an autosomal dominant inheritance pattern, characterized by small arteriovenous malformations (AVMs) on the mucous membranes and skin (telangiectasias), as well as larger visceral AVMs in the lungs, liver, and brain. This article presents a clinical case of Osler-Rendu-Weber disease affecting the respiratory system and brain in a 45-year-old female patient. A diagnostic algorithm for suspected hereditary hemorrhagic telangiectasia is also proposed.